Abstract
Aims : To determine the economic costs and the burden of dengue disease in Cavite Province, one of the areas highly inflicted by dengue disease in the Philippines. Methods: This study used Disability Adjusted Life Years (DALYs) to calculate burden of dengue disease and quantified direct and indirect costs due to hospitalization and ambulatory dengue cases. DALYs were estimated using methods developed by the World Health Organization and the World Bank. We specifically calculated Years of Life Lost from 2009 to 2014 using patient-level data from hospitals and derived Years Lived with Disability from hospital records of dengue specific type (dengue fever/dengue hemorrhagic fever) in Cavite Province. Results: An annual cost of Philippine Peso (PHP) 99,147,173 which is equivalent to United States Dollar (USD) 2,300,000 was obtained. The average annual cost per dengue case was PHP 32,324 (USD 734). The 21-25 age sub-groups had the highest average annual direct cost which amounted to PHP 243,181 (USD 5,526), followed by the 45-54 age sub-groups which amounted to PHP 201,481 (USD 4,579). From 2009 to 2014, the annual burden of disease was estimated at 178,282 DALYs (equivalent to one DALY lost per 17 persons in Cavite Province). Conclusions: The estimates of costs and DALYs suggested substantial dengue disease burden and economic costs in Cavite Province, Philippines.
Highlights
Dengue disease, a mosquito-borne viral infection, is estimated to affect more than 30% of the world population in 2055 [1]
The 21-25 age sub-groups had the highest average annual direct cost which amounted to Philippine Peso (PHP) 243,181 (USD 5,526), followed by the 45-54 age sub-groups which amounted to PHP 201,481 (USD 4,579)
We obtained an annual cost of PHP 99,147,173 which is equivalent to United States Dollar (USD) 2,300,000 (PHP 44=USD 1) [42] or total direct cost for the six-year period amounting to PHP 594,883,039 (USD 13,500,000) (Table 2)
Summary
A mosquito-borne viral infection, is estimated to affect more than 30% of the world population in 2055 [1]. Epidemiological information on dengue in the Philippines has been for the most part based on cross country national studies in Southeast Asia using multiple published reports with little or no independent regional studies to track demographic information to decision-making [7,8]. All of these have raised concern on data gaps about a disease for which currently no vaccine exists
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
